Correction
Following the publication of this article [1], the authors noticed that they incorrectly reported the Absolute risk of ischemic stroke in women aged 20 to 44 years in relation to the use of hormonal contraception and migraine status due to a miscalculation. They apologize for this misreported result.
The correct version of Table 4 has been included in this correction.
Table 4.
(Revised) Absolute risk of ischemic stroke in women aged 20 to 44 years in relation to the use of hormonal contraception and migraine status
| No migraine | Migraine with aura | Migraine without aura | |
|---|---|---|---|
| Without hormonal contraception | 2.5/100,000 | 5.9/100,000 | 4.0/100,000 |
| With hormonal contraception | 6.3/100,000 | 14.5/100,000 | 10.0/100,000 |
Considering women with migraine with aura, the risk of ischemic stroke in those young women who do not use HC is 5.9/100,000 per year whereas the same risk among those young women who use HC is 14.5 /100,000 per year
Considering women with migraine without aura, the risk of ischemic stroke in those young women who do not use HC is 4.0/100,000 per year whereas the same risk among those young women who use HC is 10.0/100,000 per year
Footnotes
The original article can be found online at 10.1186/s10194-017-0815-1
Reference
- 1.Sacco S, et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) J Headache Pain. 2018;18:108. doi: 10.1186/s10194-017-0815-1. [DOI] [PMC free article] [PubMed] [Google Scholar]